A study investigated the association between low to moderate alcohol consumption prior to primary hip and knee arthroplasty and postoperative mortality and morbidity.
30,799 patients who underwent primary hip or knee arthroplasty between January 1st, 2005 and October 8th, 2011 with information on preoperative alcohol consumption were identified through the Danish Anesthesia Database. Alcohol consumption was categorised as 0 grams of pure alcohol/week, >0-168 g/week, >168-252 g/week, and >252 g/week.
The 90-day and 1-year risks of mortality (primary outcomes), 1-year risk of prosthetic infection, and 30- day risks of cardiovascular disease and deep venous thrombosis (secondary outcomes) were estimated by Cox regression analysis.
285 (0.9%) deaths occurred within the first 90 days and 694 (2.3%) within the first year. Within the first 30 days, 209 (0.7%) and 270 (0.9%) patients had acquired cardiovascular disease and deep venous thrombosis, respectively, and 514 (1.7%) patients developed prosthetic infection within the first year.
The adjusted mortality models yielded hazard ratios of 0.55 (95% confidence interval [CI] 0.41 to 0.74) at 90 days and 0.61 (95% CI 0.51 to 0.73) at 1 year for the group consuming >0-168 g/week when compared to abstainers. Adjusted hazard ratios showed that the group consuming >0-168 g/week had a 0.91 (95% CI 0.75 to 1.11) risk of prosthetic infection, 0.68 (95% CI 0.50 to 0.92) risk of cardiovascular disease and 0.88 (95% CI 0.67 to 1.15) risk of deep venous thrombosis when compared to abstainers.
The study demonstrates that low-to-moderate alcohol consumption prior to primary hip or knee arthroplasty is associated with lower risks of mortality at both 90 days and 1 year after surgery and of cardiovascular disease after 30 days. More research from longitudinal studies is needed to identify specific causal relations and explanations.
Source: Alcohol consumption and the risk of postoperative mortality and morbidity after primary hip or knee arthroplasty - a register-based cohort study. Rotevatn TA, Boggild H, Olesen CR, Torp Pedersen C, Mortensen RN, Jensen PF, Overgaard C. PLoS One. Vol 12, No 3, 2017, Art No e0173083, 16pp.